Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm<sup>®</sup>- and placebo-controlled trial (BRIDGE)

2016145 citationsJournal Articlebronze Open Access

Authors

LAS41008 (DMF) is effective in the treatment of adults with moderate-to-severe chronic plaque psoriasis.

Good health and well-being

Published in: British Journal of Dermatology

Volume 176, Issue 3, pp. 615-623

Field-Weighted Citation Impact: 6.06